C26.9 Código facturable y específico Malignant neoplasm of ill-defined sites within the digestive system
ICD-10-CM C26.9 identifies “Malignant neoplasm of ill-defined sites within the digestive system” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 2: Neoplasms
Instrucciones del código
Inclusion terms2
- Malignant neoplasm of alimentary canal or tract NOS
- Malignant neoplasm of gastrointestinal tract NOS
Instrucciones de niveles superiores
Capítulos 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C15-C26 · Malignant neoplasms of digestive organs (C15-C26)
Excludes 11
Kaposi's sarcoma of gastrointestinal sites (C46.4)
Excludes 21
gastrointestinal stromal tumors (C49.A-)
C26 · Malignant neoplasm of other and ill-defined digestive organs
Excludes 11
malignant neoplasm of peritoneum and retroperitoneum (C48.-)
Referencias del índice oficial
Referencias del índice oficial (5)
Neoplasm, neoplastic (5)
- Neoplasm, neoplastic › alimentary canal or tract NECNeoplasias
- Neoplasm, neoplastic › digestive organs, system, tube, or tract NECNeoplasias
- Neoplasm, neoplastic › gastrocolicNeoplasias
- Neoplasm, neoplastic › gastrointestinal(tract) NECNeoplasias
- Neoplasm, neoplastic › peritoneum, peritoneal(cavity) › overlapping lesion › with digestive organsNeoplasias
Historial
Historial del código
Último cambio registrado · FY2017
Vigente desde
- Cambios en instrucciones heredadas
Malignant neoplasm of ill-defined sites within the digestive system
Código de diagnóstico facturable
CDC/NCHS · FY2017Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Cambios en instrucciones heredadas |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Sin cambios tabulares |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Sin cambios tabulares |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Sin cambios tabulares |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Sin cambios tabulares |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Sin cambios tabulares |
| FY2026 | 2025-10-01 | Sin cambios tabulares |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Correspondencias históricas ICD-9 · 2018
Solo correspondencia histórica; no sustituye códigos automáticamente.
- 159.8 · Aproximada
- 159.9 · Aproximada
Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.